Tufts Center for the Study of Drug Development Pegs Cost of a New Prescription Medicine at $802 Million
November 30, 2001

More Biotechnology Products Being Approved, But Taking Longer to Develop
November 13, 2001

Tufts Center for the Study of Drug Development to Disclose on Nov. 30 the Cost of Developing a New Drug
October 30, 2001

Leading Pharmaceutical Companies Are Using One Controlled Study to Make Their Case to the FDA
September 26, 2001

New Biopharmaceuticals Require Fewer Studies than Pharmaceuticals
July 16, 2001

Quicker R&D Decisions Are Key to Improving Drug Success Rates
May 16, 2001

Disease Management in U.S. Now Covers a Broad Range of Chronic Illnesses
March 22, 2001